|
1
|
Lieberman DA, Holub JL, Moravec MD, Eisen
GM, Peters D and Morris CD: Prevalence of colon polyps detected by
colonoscopy screening in asymptomatic black and white patients.
JAMA. 300:1417–1422. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Alexander D, Jhala N, Chatla C, et al:
High-grade tumor differentiation is an indicator of poor prognosis
in African Americans with colonic adenocarcinomas. Cancer.
103:2163–2170. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chien C, Morimoto LM, Tom J and Li CI:
Differences in colorectal carcinoma stage and survival by race and
ethnicity. Cancer. 104:629–639. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Clegg LX, Li FP, Hankey BF, Chu K and
Edwards BK: Cancer survival among US whites and minorities: a SEER
(Surveillance, Epidemiology, and End Results) Program
population-based study. Arch Intern Med. 162:1985–1993. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cooper GS, Yuan Z and Rimm AA: Racial
disparity in the incidence and case-fatality of colorectal cancer:
analysis of 329 United States counties. Cancer Epidemiol Biomarkers
Prev. 6:283–285. 1997.
|
|
6
|
Hodgson DC, Fuchs CS and Ayanian JZ:
Impact of patient and provider characteristics on the treatment and
outcomes of colorectal cancer. J Natl Cancer Inst. 93:501–515.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hodgson DC, Zhang W, Zaslavsky AM, Fuchs
CS, Wright WE and Ayanian JZ: Relation of hospital volume to
colostomy rates and survival for patients with rectal cancer. J
Natl Cancer Inst. 95:708–716. 2003.
|
|
8
|
Mayberry RM, Coates RJ, Hill HA, et al:
Determinants of black/white differences in colon cancer survival. J
Natl Cancer Inst. 87:1686–1693. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ries LAG, Kosary CL, Hankey BF, Miller BA,
Harras A and Edwards BK: SEER Cancer Statistics Review, 1973–1994.
National Cancer Institute; Bethesda, MD: 1997
|
|
10
|
Weber TK, Chin HM, Rodriguez-Bigas M, et
al: Novel hMLH1 and hMSH2 germline mutations in African Americans
with colorectal cancer. JAMA. 281:2316–2320. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Carethers JM: Racial and ethnic factors in
the genetic pathogenesis of colorectal cancer. J Assoc Acad Minor
Phys. 10:59–67. 1999.PubMed/NCBI
|
|
12
|
Heneghan HM, Miller N, Lowery AJ, Sweeney
KJ and Kerin MJ: MicroRNAs as novel biomarkers for breast cancer. J
Oncol. 2009:9502012009.PubMed/NCBI
|
|
13
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang L, Belaguli N and Berger DH: MicroRNA
and colorectal cancer. World J Surg. 33:638–646. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cummins JM, He Y, Leary RJ, et al: The
colorectal microRNAome. Proc Natl Acad Sci USA. 103:3687–3692.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Callari M, Dugo M, Musella V, et al:
Comparison of microarray platforms for measuring differential
microRNA expression in paired normal/cancer colon tissues. PLoS
One. 7:e451052012. View Article : Google Scholar
|
|
17
|
Schetter AJ, Leung SY, Sohn JJ, et al:
MicroRNA expression profiles associated with prognosis and
therapeutic outcome in colon adenocarcinoma. JAMA. 299:425–436.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schepeler T, Reinert JT, Ostenfeld MS, et
al: Diagnostic and prognostic microRNAs in stage II colon cancer.
Cancer Res. 68:6416–6424. 2008. View Article : Google Scholar
|
|
19
|
Sarver AL, French AJ, Borralho PM, et al:
Human colon cancer profiles show differential microRNA expression
depending on mismatch repair status and are characteristic of
undifferentiated proliferative states. BMC Cancer. 9:4012009.
View Article : Google Scholar
|
|
20
|
Xi Y, Shalgi R, Fodstad O, Pilpel Y and Ju
J: Differentially regulated micro-RNAs and actively translated
messenger RNA transcripts by tumor suppressor p53 in colon cancer.
Clin Cancer Res. 12:2014–2024. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fu J, Tang W, Du P, et al: Identifying
microRNA-mRNA regulatory network in colorectal cancer by a
combination of expression profile and bioinformatics analysis. BMC
Syst Biol. 6:682012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He L, Thomson JM, Hemann MT, et al: A
microRNA polycistron as a potential human oncogene. Nature.
435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Voorhoeve PM, le Sage C, Schrier M, et al:
A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in
testicular germ cell tumors. Cell. 124:1169–1181. 2006. View Article : Google Scholar
|
|
24
|
Shell S, Park SM, Radjabi AR, et al: Let-7
expression defines two differentiation stages of cancer. Proc Natl
Acad Sci USA. 104:11400–11405. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang Q, Gumireddy K, Schrier M, et al:
The microRNAs miR-373 and miR-520c promote tumour invasion and
metastasis. Nat Cell Biol. 10:202–210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tusher VG, Tibshirani R and Chu G:
Significance analysis of microarrays applied to the ionizing
radiation response. Proc Natl Acad Sci USA. 98:5116–5121. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Peltier HJ and Latham GJ: Normalization of
microRNA expression levels in quantitative RT-PCR assays:
identification of suitable reference RNA targets in normal and
cancerous human solid tissues. RNA. 14:844–852. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou BY and Wong WH: A bootstrap-based
non-parametric ANOVA method with applications to factorial
microarray data. Statistica Sinica. 21:495–514. 2011. View Article : Google Scholar
|
|
29
|
Xu XM, Qian JC, Deng ZL, et al: Expression
of miR-21, miR-31, miR-96 and miR-135b is correlated with the
clinical parameters of colorectal cancer. Oncol Lett. 4:339–345.
2012.PubMed/NCBI
|
|
30
|
Meiri E, Levy A, Benjamin H, et al:
Discovery of microRNAs and other small RNAs in solid tumors.
Nucleic Acids Res. 38:6234–6246. 2010. View Article : Google Scholar
|
|
31
|
Reid JF, Sokolova V, Zoni E, et al: miRNA
profiling in colorectal cancer highlights miR-1 involvement in
MET-dependent proliferation. Mol Cancer Res. 10:504–515. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hamfjord J, Stangeland AM, Hughes T, et
al: Differential expression of miRNAs in colorectal cancer:
comparison of paired tumor tissue and adjacent normal mucosa using
high-throughput sequencing. PLoS One. 7:e341502012. View Article : Google Scholar
|
|
33
|
Piepoli A, Tavano F, Copetti M, et al:
MiRNA expression profiles identify drivers in colorectal and
pancreatic cancers. PLoS One. 7:e336632012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu H, Du L, Wen Z, et al: Up-regulation
of miR-182 expression in colorectal cancer tissues and its
prognostic value. Int J Colorectal Dis. 28:697–703. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Myatt SS and Lam EW: The emerging roles of
forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 7:847–859.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Paik JH, Kollipara R, Chu G, et al: FoxOs
are lineage-restricted redundant tumor suppressors and regulate
endothelial cell homeostasis. Cell. 128:309–323. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
CGA N: Comprehensive molecular
characterization of human colon and rectal cancer. Nature.
487:330–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bovell LC, Shanmugam C, Putcha BD, et al:
The prognostic value of microRNAs varies with patient
race/ethnicity and stage of colorectal cancer. Clin Cancer Res.
19:3955–3965. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
He LY, Wei X, Du L, et al: Remarkably
reduced expression of FoxO3a in metaplastic colorectum, primary
colorectal cancer and liver metastasis. J Huazhong Univ Sci
Technolog Med Sci. 33:205–211. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huynh C, Segura MF, Gaziel-Sovran A, et
al: Efficient in vivo microRNA targeting of liver metastasis.
Oncogene. 30:1481–1488. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kauh J, Brawley OW and Berger M: Racial
disparities in colorectal cancer. Curr Probl Cancer. 31:123–133.
2007. View Article : Google Scholar
|
|
42
|
Carethers JM, Chauhan DP, Fink D, et al:
Mismatch repair proficiency and in vitro response to
5-fluorouracil. Gastroenterology. 117:123–131. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu S, Howell PM and Riker AI:
Up-regulation of miR-182 expression after epigenetic modulation of
human melanoma cells. Ann Surg Oncol. 20:1745–1752. 2013.
View Article : Google Scholar : PubMed/NCBI
|
